Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : WR's Momentum Trades -- Ignore unavailable to you. Want to Upgrade?

To: LANCE B who wrote (7290)	6/17/2000 5:08:00 PM
From: Wayne Rumball	Read Replies (3) \| Respond to of 11130

Hard to argue with your list. I like them all... ENET and ROTI I especially like. Toss in PBTK

To: LANCE B who wrote (7290)	6/17/2000 5:30:00 PM
From: Tom Allinder	Read Replies (1) \| Respond to of 11130

Lance, good stocks... yes it is great to come back to the place that started my good fortune :) EDOC... I have been following the company carefully. I have a lot of DD on it and I will be posting it soon. I think this stands a great chance for being a big winner when the market firms up a little. Many stocks have returned to previous lows. It depends on the market and how much money can come back into it... and of course, when. Another one to look at... still working on it... a China play is VOPT. And of course, we can't forget the fact that all the big stuff NSTG has been working on will be online within the next 3 months. Tom

To: LANCE B who wrote (7290)	6/17/2000 6:10:00 PM
From: LANCE B	Respond to of 11130

Neurotech Adds $90,000,000 Of New Projects In China NEW YORK, May 31 /PRNewswire/ -- Neurotech Development Corporation (OTC Bulletin Board: NURO) announced today that it has entered into a series of additional new contracts in China. These additional contracts are a result of the years of diligent effort, perseverance, expertise and additional strategic relationships. 50,000,000 90 Acre Senior Citizens community with Geriatric Hospital Neurotech has entered into agreement with Shanghai Dadian Biological Technology Development Co. Ltd., to develop a 90 acre senior citizen community with a 50 bed geriatric care hospital. These facilities will include a full recreation area plus 1000 apartments featuring 2000 beds of assisted living and 34 units consisting of 200 beds in a ward configuration. The hospital will be host to a complete geriatric database, and will evaluate, test, and clinically record data on traditional Chinese medicines. This $50,000,000 senior care community is one of many planned senior residential communities designed to address the aging problem of the Chinese population. This is one of the largest planned geriatric communities in China. These facilities will be operated by Shanghai Dadian Biological Technology Development Co. Ltd., and will be opened in phases. These facilities are anticipated to take 3 years to complete. All architectural drawings, relevant models, geological surveys, engineering reports and statistical data have been completed and filed with the appropriate governmental authorities. The company anticipates that the earliest commencement date for this project would be October 2000. The company and its strategic partner are confident that the term and budgets for this project are commercially reasonable. 40,000,000 Cancer Research and Treatment Hospital Neurotech has entered into agreement to build the No. 4 People's Hospital Tai-Xing City, Jiangsu Province and Ren'ai Tumours Therapeutic Centre and Jiangsu Development Authority. This is a multi-tiered project which will incorporate numerous entities into a single treatment and research center specializing in the diagnosis and treatment of cancers, with specialties in liver and stomach cancer. Combinations of refined western diagnostics will be deployed in conjunction with treatments utilizing traditional Chinese medicines and therapies, as well as western surgical practices, and treatments. The hospital is anticipated to be 150,000 sq. feet, with a minimum of 250 beds, with fully enhanced outpatient services departments, trauma center, helipad, research and education center. This facility is anticipated to take 3 years to complete, and will cost approximately $40,000,000. The statements contained in this news release which are not historical facts may be "forward-looking" statements that involve risk and uncertainties which could cause material results to differ materially from those anticipated. For example, statements that describe the companies hopes, plans, goals, intentions and expectations are forward-looking statements and are only made as of the date of this news release. Numerous factors, many of which are beyond the company's control, may affect actual results. The company undertakes no responsibility to update such forward-looking statements to reflect subsequent events or circumstances. SOURCE Neurotech Development Corporation CO: Neurotech Development Corporation; Shanghai Dadjan Biological Technology Development Co. Ltd. ST: New York, China IN: HEA MTC SU: CON 05/31/2000 11:03 EDT prnewswire.com

To: LANCE B who wrote (7290)	6/17/2000 6:12:00 PM
From: LANCE B	Respond to of 11130

Allowability' for the Patent On the Intellectual Property of the Viral Project HOUSTON--(BUSINESS WIRE)--June 16, 2000--Pathobiotek Diagnostics Inc. (OTC BB: PBTK ; pathobiotek.com), a developer of products for the diagnosis and evaluation of treatment for multiple sclerosis (MS) and other immune disorders, announced the receipt of the "Certificate of Allowability" for the patent. The actual issuance of the patent is now a formality, which will occur within a few days after the paperwork is returned to the patent office. Our investigations have demonstrated that the Activating Virus (AV) is a novel virus found in humans with a variety of cancers and immunosuppressive diseases plus marmosets with wasting syndrome. Wasting syndrome in marmosets resembles AIDS in humans. AV is associated with cancerous cell lines and may be an cofactor in human tumors. Studies to further characterize the genetic composition of this virus are ongoing. The commercial value of this patent has enormous upside potential and could be of significant financial benefit to Pathobiotek. Additional information on Pathobiotek Diagnostics Inc. can be obtained at pathobiotek.com. Safe Harbor for Forward-Looking Statements: Except for historical information contained herein, the statements in this press release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. These risks and uncertainties include, among other things, product price volatility, product demand, market competition, risk inherent in the company's domestic and international operations, imprecision in estimating product reserves and the company's ability to replace and expand its holdings. CONTACT: Pathobiotek Diagnostics Inc. Investor Relations, 713/939-1833 Ext. 300 pathobiotek.com KEYWORD: TEXAS BW0121 JUN 16,2000

To: LANCE B who wrote (7290)	6/17/2000 6:12:00 PM
From: LANCE B	Respond to of 11130

Tanner's Restaurant Group, Inc. Announces New BusinessPursuit and Acquisition NORCROSS, Ga., June 16 /PRNewswire/ -- Tanner's Restaurant Group, Inc. (OTC Bulletin Board: ROTI) announced today that the business plan of the Company will focus on the convergence and integration of international long distance telecommunications and Internet services. To establish a starting point for this new direction, Tanner's has acquired all of the shares of Fone.com, a United Kingdom corporation, from DCI Telecommunications, Inc. (OTC: DCTC). Fone.com is being renamed to B4B Communications, LTD immediately to more accurately describe the company's focus. B4B is an early stage business with ongoing operations and revenue generating products and services. While not yet profitable, management expects B4B will experience both short and long term growth in revenues and profits from pursuing high demand business in the international marketplace for the year 2000 and beyond. Note: This press release contains forward-looking statements within the meaning of Section 27-A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although Tanner's believes the expectations reflected in the forward-looking statements are based on reasonable assumptions, Tanner's actual events or results could differ materially from those set forth in the forward-looking statements. SOURCE Tanner's Restaurant Group, Inc. CO: Tanner's Restaurant Group, Inc. ST: Georgia IN: RST CPR TLS SU: PDT TNM 06/16/2000 09:00 EDT prnewswire.com